Hempnewsbreaks Astrotech Corp. (NASDAQ: ASTC) Approved As US Government Vendor, Proprietary TRACER 1000 Listed On GSA


(MENAFN- Investor Brand Network) Astrotech (NASDAQ: ASTC) , an innovative science and technology company, and its wholly owned subsidiary, 1st
Detect Corporation, have announced that its TRACER 1000(TM) is now listed in the U.S. General Services Administration (“GSA”) IT Schedule 70, making the company an approved U.S. government vendor. The device can be found under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number
334290.
According to the announcement, IT Schedule 70 is a long-term contract issued to commercial Technology vendors that allows sales to the U.S. government, one of the largest buyers of goods and services in the world. A high-performance laboratory instrument of ruggedized mass spectrometry, 1st Detect's TRACER 1000 can identify traces of explosives and narcotics. The company also announced that 1st Detect has engaged with SRI Group LLC, a distinguished GSA provider headed by John Halinski, the retired deputy administrator of the Transportation Security Administration (“TSA”).“The Astrotech Mass Spectrometer Technology(TM) drives the breakthrough TRACER 1000, as the first certified Explosives Trace Detection ('ETD') to employ mass spectrometry,” said the company in the press release.“We believe the TRACER 1000 is inexpensive, small and easy to use, with high resolution and near-zero false alarms. The TRACER 1000 is the only mass spectrometry-based ETD to have received European Civil Aviation Conference certification for both checkpoint and cargo security.”

To view the full press release, visit

About Astrotech Corp.

Astrotech is an innovative science and technology company that invents, acquires and commercializes technological innovations while building scalable companies to maximize shareholder value. 1st Detect develops, manufactures and sells trace detectors for use in the security and detection market.
For more information, please visit .

NOTE TO INVESTORS: The latest news and updates relating to ASTC are available in the company's newsroom at

About HempWire

HempWire
(“HW”) is a specialized communications platform with a focus on hemp-related news, information, and the latest developments in the hemp sector.
HempWire
is one of 60+ brands within
the
Dynamic Brand Portfolio
@
IBN
that delivers :
(1) access to a vast network of wire solutions via
InvestorWire
to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ;
(2) article and
editorial syndication to 5,000+ outlets ;
(3) enhanced
press release enhancement
to ensure maximum impact ;
(4)
social media distribution
via IBN to millions of social media followers ;
and (5) a full array of tailored
corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, HW brings its clients unparalleled recognition and brand awareness. HW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from HempWire, text“HempWire” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published:
/Disclaimer

HempWire
Denver, Colorado

303.498.7722 Office
[email protected]

HempWire is powered by
IBN

MENAFN03012025000224011066ID1109051658


Investor Brand Network

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Newsletter